Daniels, Benjamin http://orcid.org/0000-0001-8617-6055
Kiely, Belinda E.
Lord, Sarah J.
Houssami, Nehmat
Lu, Christine Y.
Ward, Robyn L.
Pearson, Sallie-Anne
Funding for this research was provided by:
Cancer Australia (1050648)
National Health and Medical Research Council (1060407, 1094325)
Sydney Catalyst (no award number)
National Breast Cancer Foundation (no award number)
Article History
Received: 2 January 2018
Accepted: 28 April 2018
First Online: 7 May 2018
Compliance with ethical standards
:
: BEK has received conference support and a speaker’s honorarium from Roche. RLW is a member of the Pharmaceutical Benefits Advisory Committee (PBAC) and SAP is a member of the Drug Utilisation Sub Committee of the PBAC. The views expressed in this paper do not represent those of the either committee. The remaining authors declare no conflicts of interest.